- Home
- VNDA vs MQT Comparison
VNDA vs MQT Comparison
Compare VNDA & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- MQT
- Stock Information
- Founded
- VNDA 2002
- MQT 1992
- Country
- VNDA United States
- MQT United States
- Employees
- VNDA N/A
- MQT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- MQT Investment Bankers/Brokers/Service
- Sector
- VNDA Health Care
- MQT Finance
- Exchange
- VNDA Nasdaq
- MQT Nasdaq
- Market Cap
- VNDA 249.4M
- MQT 222.2M
- IPO Year
- VNDA 2006
- MQT N/A
- Fundamental
- Price
- VNDA $5.46
- MQT N/A
- Analyst Decision
- VNDA Strong Buy
- MQT
- Analyst Count
- VNDA 2
- MQT 0
- Target Price
- VNDA $16.50
- MQT N/A
- AVG Volume (30 Days)
- VNDA 503.6K
- MQT 52.5K
- Earning Date
- VNDA 11-05-2025
- MQT 01-01-0001
- Dividend Yield
- VNDA N/A
- MQT 4.60%
- EPS Growth
- VNDA N/A
- MQT N/A
- EPS
- VNDA N/A
- MQT N/A
- Revenue
- VNDA $203,467,000.00
- MQT N/A
- Revenue This Year
- VNDA $15.45
- MQT N/A
- Revenue Next Year
- VNDA $37.82
- MQT N/A
- P/E Ratio
- VNDA N/A
- MQT N/A
- Revenue Growth
- VNDA 11.78
- MQT N/A
- 52 Week Low
- VNDA $3.81
- MQT $8.59
- 52 Week High
- VNDA $5.59
- MQT $10.67
- Technical
- Relative Strength Index (RSI)
- VNDA 67.52
- MQT 61.71
- Support Level
- VNDA $5.22
- MQT $10.03
- Resistance Level
- VNDA $5.48
- MQT $10.17
- Average True Range (ATR)
- VNDA 0.21
- MQT 0.06
- MACD
- VNDA 0.06
- MQT -0.02
- Stochastic Oscillator
- VNDA 90.31
- MQT 63.41
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, Housing, Corporate, and Tobacco.